Bioforce Nanosciences Holdings, Inc.
BFNH OTC
SEC CIK 1310488
Follow Bioforce Nanosciences
Weekly email: filings, results, news
Net income
$238.7K
+294.4% vs same quarter last year
EPS, diluted
$0.01
Operating cash flow
−$27K
+3.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$1.3M |
| FY24 | - | −$490.4K |
| FY23 | - | −$472K |
| FY22 | - | −$485.5K |
| FY21 | - | −$502K |
| FY20 | - | −$158.4M |
| FY19 | $17.8K | −$46.5K |
| FY18 | $16.3K | −$67.7K |
| FY17 | $4.5K | −$31.3K |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | 24.5% | −261.8% | −261.8% |
| FY18 | 28.6% | −409.2% | −415.3% |
| FY17 | 27.9% | −694.7% | −694.7% |
| FY16 | - | - | - |
- Bioforce Nanosciences
- Technology median
Show the numbers
| Year | Bioforce Nanosciences | Technology median |
|---|---|---|
| FY25 | - | 8.4% |
| FY24 | - | 8.9% |
| FY23 | - | 7.7% |
| FY22 | - | 5.9% |
| FY21 | - | 9.8% |
| FY20 | - | 4.5% |
| FY19 | −261.8% | 8.6% |
| FY18 | −415.3% | 6.3% |
| FY17 | −694.7% | 6.4% |
| FY16 | - | 5.3% |
News
No stories filed under Bioforce Nanosciences yet - coverage appears here as the news feed clusters it.